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Nontransformed cells can force tumor cells to assume a nor-
mal morphology and phenotype by the process of contact nor-
malization. Transformed cells must escape this process to
become invasive and malignant. However, mechanisms under-
lying contact normalization have not been elucidated. Here, we
have identified genes that are affected by contact normalization
of Src-transformed cells. Tumor cells must migrate to become
invasive and malignant. Src must phosphorylate the adaptor
protein Cas (Crk-associated substrate) to promote tumor cell
motility.We report here that Src utilizes Cas to induce podopla-
nin (Pdpn) expression to promote tumor cell migration. Pdpn is
a membrane-bound extracellular glycoprotein that associates
with endogenous ligands to promote tumor cell migration lead-
ing to cancer invasion and metastasis. In fact, Pdpn expression
accounted for a major part of the increased migration seen in
Src-transformed cells. Moreover, nontransformed cells sup-
pressed Pdpn expression in adjacent Src-transformed cells. Of
>39,000 genes, Pdpn was one of only 23 genes found to be
induced by transforming Src activity and suppressed by contact
normalization of Src-transformed cells. In addition, we found
16 genes suppressed by Src and induced by contact normaliza-
tion. These genes encode growth factor receptors, adaptor pro-
teins, and products that have not yet been annotated and may
play important roles in tumor cell growth and migration.
Cells transformed by a variety of chemicals, viral agents, and
oncogenes, including Src, can be normalized by contact with
nontransformed cells. This process is called “contact normal-
ization” (1, 2). Genetically transformed cells can assume a nor-
mal morphology and reside in many organs, including skin,
breast, and intestine, while they are normalized by contact with
adjacent normal cells (for review, see Refs. 1, 2). Transformed
cells must escape this form of growth control to “break out” of
their microenvironment and invade new sights. The ability of
tumor cells to migrate is critical for this process.
Src is a membrane-bound tyrosine kinase that has been
implicated in many types of cancer (3). Src phosphorylates the
focal adhesion adaptor protein Cas2 (Crk-associated substrate)
to promote the nonanchored growth and migration required
for tumor cell invasion andmetastasis. Therefore, Src transfor-
mation of homozygous null Cas knock-out (CasKo) cells does
not fully promote their anchorage independence or ability to
migrate. These transformed growth characteristics can be con-
ferred to CasKo cells by transfection with wild type Cas (4–7).
Although the importance of Src and Cas in tumor cell
migration has been well documented, mechanisms by which
Src promotes cell migration have not been thoroughly eluci-
dated. We hypothesized that contact normalization could be
used to help elucidate these mechanisms. We used a nonbi-
ased comprehensive strategy to find genes affected by Src
and contact normalization.
Here, we show that Src utilizes Cas to induce podoplanin
(Pdpn) expression, which is suppressed during contact normal-
ization of Src-transformed cells. Pdpn is a membrane-bound
extracellular glycoprotein that associates with endogenous
ligands to promote tumor cellmigration leading to cancer inva-
sion andmetastasis (8–10). In addition, we identify other genes
affected by contact normalization that play important roles in
tumor cell growth and migration, including growth factor
receptors, adaptor proteins, and genes that have not yet been
annotated.
EXPERIMENTAL PROCEDURES
Cell Culture—Nontransformed and Src-transformed wild
type mouse embryonic fibroblasts, homozygous null Cx43
knock-out brain cells (Cx43Ko), and homozygous null Cas
knock-out cells (CasKo) have been described previously (6,
11–13). Cells were maintained in Dulbecco’s modified Eagle’s
medium (HyClone SH30021.01) supplemented with 25 mM
HEPES and 10% bovine growth serum (HyClone SH30541.03)
at 37 °C, 5% CO2, and 100% humidity. cDNA encoding murine
Pdpn or Tmem163 was released from pCMV-Sports-pdpn
(Open Biosystems MMM1013-7513215) or pYX-Asc-Tmem163
(Open BiosystemsMMM1013-98685813) with EcoRI and XbaI
and inserted into the complementary sites of pEF4 to create
pEF4Pdpn or pEF4Tmem163, respectively. Cells were trans-
fected with pEF4Pdpn, empty pEF4 vector, siRNA directed
againstmouse Pdpn (Dharmacon L-048117-01-005), or control
siRNA (Dharmacon D-001810--10-05) with Lipofectamine
2000 (14, 15). Cells transfected with pEF4 expression vectors
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were selected with zeocin. Clones were not taken from any cell
lines, thus minimizing potential effects of clonal variation.
Layered Culture System—A layered culture system was used
to allow separated populations of transformed and nontrans-
formed cells to form intercellular junctions with each other as
described (13, 16). Briefly, 10,000 Src-transformed cells were
plated on porousmembranes (Costar 3542) containing 300,000
nontransformed cells on the other side. Transformed cells and
nontransformed cells were able to form intercellular junctions
through the pores in the membrane; however, the membrane
pore size (3 m) is small enough to prevent cells (about 20 m
in diameter) from actually migrating to the other side of the
membrane (12, 13, 16). Transformed cells were also plated
alone, directly above 300,000 nontransformed cells, or 1 mm
above 300,000 nontransformed cells as controls. Nontrans-
formed cells were also plated on these membranes as controls.
Cells were harvested and analyzed 24 h after plating.
Expression Microarrays—Gene expression in nontrans-
formed, Src-transformed, and contact normalized Cx43Ko
cells was examined by microarray analysis with 430 2.0 Mouse
Expression Array gene chips (Affymetrix) as described previ-
ously (12). These arrays contain 45,000 probe sets that repre-
sent 30,000 genes. Affected probe sets displayed a difference
of at least 4-fold between transformed and control cells, or at
least a 2-fold change with p  0.05 by t test with n  3. Genes
that were increased by contact normalization were also
decreased by Src, but not affected by diffusible factors from
nontransformed cells or contact with other transformed cells.
Conversely, genes that were decreased by contact normaliza-
tion were increased by Src, but not affected by diffusible factors
from nontransformed cells or contact with other transformed
cells. All comparisons were done with cells from parallel cul-
tures to control for variability in reagents or experimental con-
ditions. Expression analysis was performed with Vector Xpres-
sion software 4.0 (Invitrogen).
RT-PCR—RNA was purified with Tri-reagent (Sigma
T9424). cDNAwas synthesized from 1 g of RNA by with Pro-
toscript First Strand cDNASynthesis Kit (New England Biolabs
E6500S). PCR was performed with 1 l of cDNA with forward



















CAC-3), and D4bwg0951e (5-TGGATGGCATCTCAGTA-
GGGAGCTA-3 and 5-TTGCACACCAGTCCCATGCAAA-
3). GAPDH was amplified at 95 °C for 5 min, 95 °C for 30 s,
55 °C for 30 s, and 72 °C for 30 s for 30 cycles, followed by 72 °C
for 5 min. Hygromycin phosphotransferase was amplified at
95 °C for 5 min, 95 °C for 30 s, and 72 °C for 1 min for 30 cycles,
followed by 72 °C for 5 min. The other genes were amplified at
95 °C for 5 min, 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s
for 30 cycles, followed by 72 °C for 5 min. qPCR was performed
with 0.5 l of cDNA amplified 95 °C for 10 min followed by
95 °C for 15 s, and 60 °C for 1 min for 30 cycles in a StepOne
RT-PCR machine with SYBR Green master mix and analyzed
with StepOne Software version 2.0 (Applied Biosystems).
Western Blotting—Western blotting was performed as de-
scribed previously (12). Protein (10 g/lane) was resolved by
SDS-PAGE, transferred to Immobilon-P membranes (Milli-
pore IH1079562), and incubatedwith antisera specific for Pdpn
(SantaCruzBiotechnology SC53553), Cas (SantaCruzBiotech-
nology SC860), active Src kinase (Cell Signaling Technology
2010), v-Src (Upstate Biotechnology 05-185), Tmem163 (raised
against the sequence VQSDEERQPRISESGQFS, representing
amino acids 43–60 of mouse Tmem163, in rabbits as described
FIGURE 1. Layered culture system. a, nontransformed or Src-transformed
Cx43Ko cells were incubated beneath or on top of a porous membrane that
prevents actual mixing of the cell populations. Transformed cells separated
by 1 mm from nontransformed cells enabled communication by diffusible
factors but not intercellular junctions. Transformed cells incubated directly
over nontransformed cells allowed for intercellular junctional communica-
tion and contact normalization. b, contact-normalized tumor cells were sep-
arately harvested and analyzed for v-Src or -actin by Western blot analysis
(20 g/lane). c, each cell layer from the contact normalized configuration was
separately harvested and analyzed by RT-PCR to detect mRNA encoding
hygromycin phosphotransferase (Hygro; conferring hygromycin resistance to
nontransformed cells), puromycin acetyltransferase (Puro; conferring puro-
mycin resistance to transformed cells), or GAPDH (as a control). v-Src protein
and puromycin acetyltransferase mRNA were retained in the transformed cell
preparations, whereas hygromycin phosphotransferase mRNA was retained
in the nontransformed cell preparations. Although RT-PCR data are only
shown from nontransformed cells plated alone, all nontransformed cells in
this system contained hygromycin phosphotransferase mRNA levels similar
to nontransformed cells plated alone and no detectable puromycin acetyl-
transferase mRNA.
Src, Cas, Pdpn, and Cell Migration






















previously) (12, 14), or -actin (Sigma A1978). Primary anti-
serum was recognized by appropriate secondary antiserum
conjugated to horseradish peroxidase and detected using
Enhanced Chemiluminescence (Millipore WBKLS0500). After
blotting, membranes were stained with India ink to verify equal
loading and transfer.
Immunofluorescence Microscopy—Cells (300,000/dish) were
cultured on 35-mm poly-D-lysine-coated glass-bottomed cul-
ture dishes (MatTekP35GC-1.5-14-C) for 24 h. Cells were fixed
with 2% paraformaldehyde, permeabilized with 0.2% Triton
X-100 in phosphate-buffered saline for 10 min, washed three
times with 0.1% Tween 20 in phosphate-buffered saline fol-
lowed by 1% bovine serum albumin in phosphate-buffered
saline for 30 min, incubated with Pdpn antiserum (1:100) over-
night at 4 °C, washed, and then labeled with goat anti-Syrian
hamster IgG conjugated to Alexa Fluor 488 (Molecular Probes
A21110). Cells were visualized on Zeiss Axiovert or PASCAL
microscope systems as described (14, 15).
Cell Growth, Migration, and Toxicity Assays—Cell growth
and migration were assayed as described previously (12, 14).
Briefly, anchored andnonanchored growthwasmeasured by plat-
ing 20,000 cells/well on standard 12-well cluster plates (Falcon
353043) or ultralow attachment 24-well cluster plates (Corning
3473), respectively, and counting cells at defined times by Coulter
counter. To examinemembrane cellmigration, 200,000 cellswere
plated on cell culture inserts with a 8-m pore size (Transwell-
Clear; Costar 3428) in 6-well cluster plates and grown for 24 h.
Cellswere then released separately from the topof themembrane,
bottom of the membrane, and well beneath the membrane and
counted. Migration and colonization was quantitated as the per-
centage of cells thatmoved to the bottomof themembraneorwell
beneath the membrane, respectively. Cell migration was also
examined by a wound-healing assay and quantitated as the num-
ber of cells that entered a 1.8-mm2 or 0.9-mm2 area of the wound
during 24 h. Cells were stainedwith 0.2% trypan blue and counted
with a hemocytometer to evaluate cytotoxicity.
TABLE 1





Genes increased by Src and decreased
during contact normalization
1700012B09Rikc 1428984_a_at 115 3.4 RIKEN cDNA 1700012B09 gene
Pdpnc 1419309_at 93 4.7 Podoplanin
Tmem163c 1428077_at 58 5.5 Transmembrane protein 163
Smoc2 1415935_at 47 6.6 SPARC-related modular calcium binding 2
Pstpip2 1421410_a_at 41 4.5 Proline-serine-threonine phosphatase-interacting protein 2
Mal 1417275_at 30 5.6 Myelin and lymphocyte protein
Lepr 1425644_at 28 4.7 Leptin receptor
Elavl2 1421883_at 26 9.9 Embryonic lethal abnormal vision-like 2
Igsf11 1460607_at 26 5.0 Immunoglobulin superfamily, member 11
Mafb 1451715_at 14 6.7 v-Maf protein B
LOC677224c 1435703_at 13 3.5 Similar to RIKEN cDNA 2810457I06
4930408O21Rikc 1431741_a_at 8.8 4.8 RIKEN cDNA 4930408O21 gene
Elmod1 1457223_at 8.3 5.0 ELMO domain-containing 1
Atp13a4 1438707_at 7.8 4.7 ATPase type 13A4
Kdr 1449379_at 6.6 3.7 Kinase insert domain protein receptor
C9 1422815_at 5.4 4.9 Complement component 9
Genes decreased by Src and increased
during contact normalization
Fgf7 1438405_at 130 46 Fibroblast growth factor 7
D10Bwg1379e 1435050_at 95 13 DNA segment Chr 10 Brigham andWomen’s Genetics 1379 expressed
Sox11 1431225_at 93 16 SRY box-containing gene 11
Ccl20 1422029_at 91 12 Chemokine (C-C motif) ligand 20
Vcam1d 1448162_at 78 22 Vascular cell adhesion molecule 1
1415989_at 56 16
1451314_a_at 55 12
Sema3e 1427673_a_at 71 8.3 Semaphorin 3E
Sdpr d 1416779_at 47 13 Serum deprivation response
1416778_at 39 11
Epha4 1429021_at 44 8.3 Eph receptor A4
Ntn1 1454974_at 42 17 Netrin 1
Cabc1 1417066_at 32 5.0 Chaperone, ABC1 activity of bc1 complex like (Schizosaccharomyces pombe)
Spry1 1415874_at 26 4.5 Sprouty homolog 1 (Drosophila)
Loxl1 1451978_at 25 9.9 Lysyl oxidase-like 1
1810008K04Rikc 1441254_at 19 9.0 RIKEN cDNA 1810008K04 gene
Pdgfrb 1436970_a_at 18 3.9 Platelet-derived growth factor receptor  polypeptide
D4Bwg0951ec 1428384_at 17 4.2 DNA segment Chr 4 Brigham andWomen’s Genetics 0951 expressed
Fhl1c,d 1417872_at 16 11 Four and a half LIM domains 1
Gpr126 1437408_at 16 5.7 G protein-coupled receptor 126
1437409_s_at 13 5.7
Egfr 1435888_at 16 5.2 Epidermal growth factor receptor
Itih2 1417618_at 12 7.3 Inter--trypsin inhibitor heavy chain 2
Epb4.1l3 1419062_at 12 5.6 Erythrocyte protein band 4.1-like 3
Il1rl1 1425145_at 9.7 8.3 Interleukin 1 receptor-like 1
Wnt5a 1448818_at 9.1 4.6 Wingless-related MMTV integration site 5A
Tmem56 1434553_at 8.2 4.4 Transmembrane protein 56
a Expression in Src-transformed cells divided by expression in nontransformed cells.
b Expression in transformed cells divided by expression in transformed cells undergoing contact normalization.
c Effects confirmed by RT-PCR (see Fig. 1).
d Genes previously shown to be induced by contact normalization.
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Identification of Genes Affected by Src and Contact
Normalization—Tumor cells must overcome contact normal-
ization by adjacent nontransformed cells in their microenvi-
ronment to become malignant or metastatic (17). We have
developed a layered culture system to identify genes involved in
this process (12, 13). Src-transformed cells were incubated on a
porousmembrane directly over nontransformed cells (see Figs.
1–3). The transformed cells and nontransformed cells were
able to form intercellular junctions through the pores in the
membrane while being retained as separate populations. Thus,
although intercellular junctions formed between the trans-
formed and nontransformed cells, the layers were retained as
distinct populations that were harvested separately. As con-
trols, transformed cells were also incubated alone, or 1mmover
FIGURE 2. RT-PCR analysis of the effects of Src and contact normalization
on the expression of several genes. Src-transformed cells were cultured on
porous membranes directly above nontransformed cells (contact normal-
ized), directly above another layer of transformed cells (Src controls), or 1 mm
above nontransformed cells (diffusible factors). Nontransformed and Src-
transformed cells were also plated alone. Each cell layer was separately har-
vested and analyzed by RT-PCR to detect mRNA species as indicated. A control
lane from reaction without reverse transcriptase is also indicated.
FIGURE 3. Effects of Src and contact normalization on Pdpn, Tmem163,
Fhl1, and GAPDH mRNA expression examined by microarrays. Src-trans-
formed cells were cultured on porous membranes directly above nontrans-
formed cells (contact normalized), directly above another layer of transformed
cells (Src controls), or 1 mm above nontransformed cells (diffusible factors).
Nontransformed and Src-transformed cells were also plated alone. Each cell
layer was separately harvested and analyzed by Affymetrix expression
microarrays to detect mRNA species as indicated. Data are shown as expres-
sion intensity from microarray analysis (mean  S.E., n  2). Configuration of
cells in the layered culture system is presented on the top of the histograms,
with the target cells filled in gray. Double and triple asterisks indicate p  0.01
and p  0.001 compared with Src-transformed cells by t test, respectively.
Src, Cas, Pdpn, and Cell Migration






















nontransformed cells to enable communication by diffusible
factors but not direct contact. As we have reported previously,
cellularmaterial is not transferred between harvested cell layers
(12–14, 16, 18). This was verified by the retention of the Src
kinase and mRNA encoding puromycin acetyltransferase in
the transformed cells and mRNA
encoding hygromycin phospho-
transferase in nontransformed cells
(Fig. 1).
We utilized Affymetrix micro-
arrays to identify genes involved
in contact normalization. About
45,000 probe sets were examined,
representing 39,000 transcripts.
The expression of genes repre-
sented by 10928 probe sets, or up to
about 25% of the transcriptome, was
affected 2-fold or more by trans-
forming Src kinase activity. The
expression of genes represented by
up to 5560 probe sets was higher in
Src-transformed cells than non-
transformed cells, whereas the
expression of genes represented by
up to 5368 probe sets was lower.
However, the expression of only 39 genes was found to be sig-
nificantly affected during contact normalization of Src-trans-
formed cells (see Table 1). The mRNA levels of several of these
genes, including Pdpn, Tmem163, Fhl1, and 5 expressed
sequence tags were verified by RT-PCR as shown in Fig. 2.
As shown in Table 1, the expression of 23 genes was sup-
pressed by Src and increased by contact normalization. Some
of these genes encode proteins that mediate events including
growth factor signaling (Fgf7, Epha4, Spry1, Pdgfrb, Gpr126,
Egfr, Wnt5a, and Il1rl1) and transcription (Sox11 and Fhl1).
Many of these genes have been implicated in the regulation
of tumor cell growth and migration. For example, recent
experiments indicate that Epb4.1l3 (erythrocyte protein
band 4.1-like 3) (19) and Itih2 (inter--trypsin inhibitor
heavy chain) (20) can suppress tumor cell invasion and
metastasis. Induction of three of these genes, Vcam1, Sdpr,
and Fhl1, has been previously associated with contact nor-
malization (13). Interestingly, these genes are candidate
biomarkers that are suppressed in malignant tumor cells
(14). For example, Src utilizes Cas to suppress Fhl1 expres-
sion to promote tumor cell migration (12).
The expression of 16 genes was increased by Src and sup-
pressed by contact normalization. These genes are of great
interest because they may be required for malignant growth
and metastasis. These genes encode proteins that mediate
events including cation (Smoc2, Atp13a4) and glutamate
(Tmem163) transport, neuronal development (Mal), energy
homeostasis (Lepr), mRNA transcription (Mafb) and stabiliza-
tion (Elavl2), cell adhesion (Igsf11), growth factor signaling
(Kdr), immunological activity (C9), and cell migration (Pdpn).
Some of these gene products may act as biomarkers and targets
for chemotherapy. For example, inhibitors have been generated
to target kinase insert domain receptor (Kdr) to prevent VEGF
signaling and suppress angiogenesis required for malignant
tumor growth (21). Immunological reagents have also been tar-
geted to immunoglobulin superfamily 11 (IGSF11) (22) and
Pdpn (23) to prevent tumor cell invasion and metastasis.
FIGURE 4. qRT-PCR analysis of the effects of Src transformation and contact normalization on the expres-
sion of Pdpn and Fhl1 mRNA. mRNA transcripts encoding Pdpn and Fhl1 from nontransformed cells, Src-
transformed cells, and contact-normalized transformed cells were examined by qRT-PCR. Values were stan-
dardized to GAPDH as an internal control and are shown as expression intensities relative to Src-transformed
cells that were normalized to a value of 1.0 (mean  S.E. (error bars), n  4).
FIGURE 5. Src utilizes Cas to augment Pdpn protein expression in trans-
formed cells. a, protein from nontransformed and Src-transformed Cx43Ko
cells, CasKo cells transfected with Cas or parental vectors, and wild type (WT)
cells was analyzed by Western blotting to detect Pdpn, v-Src, active Src, Cas,
and -actin. b, Pdpn, Src, and nuclei were visualized by immunofluorescence
microscopy in nontransformed and Src-transformed wild type and Cx43Ko
cells. Differential interference contrast images are also shown. Scale bar, 100
m.
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Src Increases Pdpn Expression in Transformed Cells—We
have found previously that Src suppresses Fhl1 expression to pro-
mote tumor cell migration and that this effect is reversed during
contact normalization (12, 14). As shown in Fig. 3, our data are
consistent with these previous reports. Fhl1 mRNA expression
was decreased by 10-fold in Src-transformed cells compared
with nontransformed cells. In addition, contact normalization
increasedFhl1mRNAlevels to thoseseen innontransformedcells.
Moreover, direct contact with other Src-transformed cells or dif-
fusible factors from nontransformed cells did not significantly
affect Fhl1 mRNA expression in transformed cells (see Fig. 3).
In contrast to Fhl1, Src increased
the expression of Pdpn, which is a
membrane-bound extracellular gly-
coprotein that associates with
endogenous ligands to promote cell
motility leading to tumor cell inva-
sion and metastasis (8–10). As
shown in Fig. 3, Src increased Pdpn
mRNA expression by nearly
10-fold. In addition, contact nor-
malization decreased Pdpn mRNA
expression in transformed cells by
about 80%. As with Fhl1, contact
with other Src-transformed cells, or
diffusible factors from nontrans-
formed cells, did not significantly
affect Pdpn expression in trans-
formed cells (see Fig. 3). As shown
in Fig. 4, the effects of Src transfor-
mation and contact normalization
on Fhl1 and Pdpn mRNA expres-
sion were confirmed by qRT-PCR,
as well as standard RT-PCR shown
in Fig. 3.
As predicted by mRNA analysis,
transforming Src kinase activity
increased Pdpn protein expres-
sion. Because the gap junction
protein Cx43 can affect trans-
formed cell migration (24, 25), the
effects of Src on Pdpn expression
were analyzed in Cx43Ko and
wild type cells. Western blotting,
shown in Fig. 5a, revealed that Src
augmented Pdpn protein expres-
sion in both cell types. These find-
ings were confirmed by immuno-
fluorescence microscopy as shown
in Fig. 5b.
Src Augments Pdpn Expression to
Promote CellMigration—The effects
of Src on Pdpn expression are
intriguing because Pdpn can pro-
mote tumor cell migration leading
to malignant and metastatic growth
(9, 23, 26). We have found previ-
ously that Src utilizes Cas to sup-
press Fhl1 expression to promote nonanchored cell growth and
migration of transformed cells (12). Therefore, the effects of Src
on Pdpn expression were examined in cells with and without
Cas. As shown in Fig. 5a, more Pdpn was found in Src-trans-
formed CasKo cells transfected with Cas than control transfec-
tants. These data indicate that Src utilizes Cas to augment Pdpn
expression and promote tumor cell migration.
The effects of Pdpn on cell motility were also examined by
transfection with cDNA. Western blot analysis, shown in Fig.
6a, demonstrates that nontransformed cells transfected with
cDNA encoding Pdpn expressed Pdpn protein levels compara-
FIGURE 6. Pdpn expression is sufficient to increase migration of nontransformed cells. a, protein from
nontransformed Cx43Ko cells transfected with cDNA encoding Pdpn, the empty parental vector (EF4), or v-Src
was examined by Western blotting to detect Pdpn or -actin. b, Pdpn (green) and nuclei (blue) were visualized
by confocal immunofluorescence microscopy. Differential interference contrast images are also shown. Scale
bar, 50 m. c, cells (20,000/well) were cultured in anchored or nonanchored conditions and counted at the time
points indicated. Data are shown as the number of cells/well (mean  S.E. (error bars), with n  2 for anchored
growth and n  4 for nonanchored growth). d, cells were plated on porous membranes and counted 24 h later.
Migration was quantitated as the percent of cells that migrated from the top of the membrane to the bottom
of the membrane, whereas colonization was quantitated as the percent of cells that migrated to the well
beneath the membrane (mean  S.E. (error bars), n  3). Triple asterisks denote p  0.001 compared with
control transfectants by t test.
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ble with Src-transformed cells. Immunofluorescent micros-
copy, shown in Fig. 6b, found Pdpn localized to the plasma
membrane where it may act as a signaling receptor (9, 23, 27).
Pdpn expression did not significantly affect the growth or
anchorage dependence of nontransformed cells (Fig. 6c). How-
ever, as shown in Fig. 6d, Pdpn expression did augment the
ability of nontransformed cells tomigrate by5-fold, achieving
levels comparable with Src-transformed cells. Thus, Pdpn did
not require transforming Src activity to promote cellmigration.
Nonetheless, because Pdpn did not augment nonanchored
growth (Fig. 6c), it was not sufficient to increase colonization of
nontransformed cells, as assayed by the ability of cells to
migrate through porous membranes and dissociate from the
membranes to attach and grow on the well 1 mm under the
membranes as shown in Fig. 6d.
The effects of Pdpn on the motility of Src-transformed cells
were examinedby transfectionwith siRNA.As shown in Fig. 7a,
Pdpn protein expression was decreased in Src-transfected cells
transfected with siRNA directed against Pdpn.Wound-healing
assays, shown in Fig. 7b and supplemental Fig. 1, indicate that
this decrease in Pdpn expression reduced the migration of
Src-transformed cells by 60%. These data indicate that Src
induces Pdpn expression to promote cell migration. However,
incomplete suppression of transformed cell migration by Pdpn
siRNA also suggests that factors other than Pdpn can increase
cell motility.
DISCUSSION
Nontransformed cells can force
tumor cells to assume a normal
morphology and phenotype by the
process of contact normalization (1,
2, 28). Contact normalization is a
powerful process. For example,
transformed keratinocytes that
comprise up to 4% of epidermal vol-
ume can be controlled in human
skin for decades (29). We sought to
identify genes expressed by trans-
formed cells that are not controlled
by contact normalization to eluci-
date novel mechanisms that lead to
tumor cell invasion and metastasis.
Src-transformed cells were used
to create a model system for these
assays. Src is a clinically relevant
oncogenic kinase that phosphory-
lates Cas to promote tumor cell
migration (4, 6, 7, 30, 31). We have
previously utilized Affymetrix U74
expression arrays to analyze the
effects of contact normalization on
the expression of about 14,000
genes (13). In the present assays, we
utilized more advanced (Affymetrix
431) expression arrays to achieve a
more reliable and comprehensive
analysis of the transcriptome.
Although approximately 25% of
39,000 transcripts examined by these arrays were affected
by transforming Src kinase activity, only 39 of these, repre-
senting approximately 0.01% of the transcriptome, were
affected by contact normalization.
In addition to confirming our previous findings that Src
inhibits the expression of the potential tumor suppressors Fhl1,
Sdpr, and Vcam1, which are induced by contact normalization
(13), the present data have identified additional candidate
tumor suppressors, as well as potential tumor promoters. Most
notably, we found that Src utilized Cas to induce Pdpn expres-
sion and that Pdpn expression was suppressed during contact
normalization of Src-transformed cells. These data are consis-
tent with reports of Fos, a component of the AP1 transcription
factor acting downstream of tumor promoters, including TPA
and Src, inducing Pdpn during skin carcinogenesis (32).
Pdpn is a well characterized biomarker that can promote
tumor cell invasion and metastasis (8–10). Indeed, our data
indicate that Pdpn signaling is both necessary and sufficient to
promote tumor cell migration. Pdpn is found at the invasive
front of many types of tumors, which is consistent with its role
in promoting malignant invasion (9, 27).
Compounds that prevent interaction between Pdpn and its
natural ligand(s) can effectively inhibit tumor cell migration
(9, 33). Clec-2 has been reported to associate with Pdpn and
increase tumor cell migration, and antiserum that blocks bind-
FIGURE 7. Pdpn expression is required to promote migration of transformed cells. a, protein from Src-
transformed Cx43Ko or wild type (WT) cells transfected with control siRNA or siRNA directed against Pdpn was
examined by Western blotting to detect Pdpn or -actin. b, cell migration was analyzed by wound healing and
quantitated as the number of cells to enter a 1.8-mm2 area in the middle of the wound in 24 h (mean  S.E., n 
4). Triple asterisks denote p  0.0001 compared with control transfectants by t test.
Src, Cas, Pdpn, and Cell Migration






















ing of Clec-2 to Pdpn can suppress tumor cell metastasis (23).
However, microarray analysis indicated that the cells used in
our study did not express Clec-2 (data not shown), which is
normally expressed by platelets (23).
Taken together, our data indicate that Pdpn acts downstream
of Src andCas to promote cellmigration. This study presents an
example of how genes that are induced by Src and suppressed
by contact normalization can be utilized as biomarkers and
promising targets for chemotherapy. For example, we have pre-
viously reported that Src utilizes Cas to suppress Fhl1 expres-
sion, which can be induced by contact normalization and sup-
press tumor cell migration (12–14). On the other side of the
coin, our data indicate that Src induces the expression of genes
that are suppressed by contact normalization and promote
tumor cell migration. In addition to Pdpn, these genes, exem-
plified by Kdr and Igsf11, may serve as biomarkers and chemo-
therapeutic targets. Kdr, which is also called Vefgr2, is a recep-
tor for Vegfa (34), and can be targeted to prevent VEGF
signaling and suppress angiogenesis required for malignant
tumor growth (21). Antisera directed against IGSF11 can also
be used to prevent tumor cell invasion and metastasis (22).
In addition to known genes, this strategy has also identified
genes involved in contact normalization that have not yet been
annotated (see Table 1), and, like Pdpn and Kdr, may also
encode transmembrane proteins that can be targeted by che-
motherapeutic reagents. For example, Tmem163 expression
was elevated in Src-transformed cells, but decreased by contact
normalization. Interestingly, elevated Tmem163 mRNA ex-
pression has also been found in papillary thyroid carcinoma
(Gene Expression Omnibus data set GDS1732/1552626) and
nodular lymphocyte-predominant Hodgkin lymphoma (35).
Tmem163 is predicted to form an integral membrane protein
with six transmembrane helices. In addition to mRNA analysis
shown in Figs. 2 and 3, Western blotting experiments indicate
that Tmem163 protein expression was elevated in transformed
cells and nontransformed cells transfected with Tmem163
cDNA.Moreover, Tmem163 transfectants grew nearly twice as
fast andmigrated several times the rate of control transfectants
(see supplemental Figs. 2 and 3). Thus, the study of genes
affected by Src and contact normalization should help elucidate
mechanisms that underlie tumor cell growth and migration.
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